Compounds > stipiamide

Page last updated: 2024-12-11

stipiamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

stipiamide: from Myxococcus stipitatus; effective towards multidrug-resistant cancer cells; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	5467322
CHEMBL ID	1970564
MeSH ID	M0189994

Synonyms (13)

Synonym
2,6,8,10,14-octadecahexaenamide, 13-hydroxy-n-[(1s)-2-hydroxy-1-methylethyl]- 2,10,12,14,16-pentamethyl-18-phenyl-,(2e,4e,6z,8e,10e,12r,13r,14e,16s)-
fenalamid a1
2,6,8,10,14-octadecahexaenamide, 13-hydroxy-n-(2-hydroxy-1-methylethyl)- 2,10,12,14,16-pentamethyl-18-phenyl-, [12r-[1(s),2e,4e,6z,8e,10e,12r,13r,14e,16s]]-
(-)-stipiamide
nsc-650717
fenalamide a1
phenalamide a1
stipiamide
nsc650717
2,4,6,8,10,14-octadecahexaenamide, 13-hydroxy-n-[(1s)-2-hydroxy-1-methylethyl]-2,10,12,14,16-pentamethyl-18-phenyl-,(2e,4e,6z,8e,10e,12r,13r,14e,16s)-
(2e,4e,6z,8e,10e,14e)-13-hydroxy-n-(2-hydroxy-1-methyl-ethyl)-2,10,12,14,16-pentamethyl-18-phenyl-octadeca-2,4,6,8,10,14-hexaenamide
(2e,4e,6z,8e,10e,14e)-13-hydroxy-n-(1-hydroxypropan-2-yl)-2,10,12,14,16-pentamethyl-18-phenyloctadeca-2,4,6,8,10,14-hexaenamide
CHEMBL1970564

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (20.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	4 (80.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
erythrosine Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.	2.02	1	0
prazosin Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.. prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.	2.02	1	0	aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines	alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
azides Azides: Organic or inorganic compounds that contain the -N3 group.. azide : Any nitrogen molecular entity containing the group -N3.	2.02	1	0	pseudohalide anion	mitochondrial respiratory-chain inhibitor
cp 65,526 azidoprazosin: labeled with 125I	2.02	1	0
calcein am calcein AM: a non-fluorescent compound cleaved to a fluorescent compound by non-specific intracellular esterases. calcein am : An organic heteropentacyclic compound that is calcein in which all four carboxy group hydrogens have been substituted by (acetyloxy)methoxy groups and the hyrodgens of the two hydroxy groups have been substituted by acetyl groups. It is a a non-fluorescent probe cleaved to a fluorescent probe by non-specific intracellular esterases.	2.02	1	0	2-benzofurans; acetate ester; gamma-lactone; organic heteropentacyclic compound; oxaspiro compound; xanthene dye	fluorochrome
8-azidoadenosine 5'-triphosphate [no description available]	2.02	1	0
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene [no description available]	2.02	1	0	BODIPY compound